15-12G ยทFiled May 4, 2026
Deregistration
Actionable Insight โข Neutral
No further trading or reporting obligations remain; the stock is no longer publicly listed. Monitor for final distributions to former shareholders, if any.
Price Chart
Loading chart...
Executive Summary
Day One Biopharmaceuticals filed Form 15 to terminate its SEC registration and suspend reporting obligations, effective May 4, 2026, following its acquisition by Servier Pharmaceuticals. The company reports only one holder of record, confirming the take-private transaction is complete.
Key Facts
- Filed Form 15-12G to terminate registration under Section 12(g) of the Exchange Act.
- Approximate number of holders of record: One.
- Follows Nasdaq delisting (Form 25) filed April 23, 2026, and acquisition by Servier Pharmaceuticals.
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (13 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001193125-26-202385 |
| Document: 0001193125-26-202385-index-headers.html | 0001193125-26-202385 |
| Document: 0001193125-26-202385-index.html | 0001193125-26-202385 |
| Document: 0001193125-26-202385.txt | 0001193125-26-202385 |
6 reports for DAWN
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
May 4, 2026 21w ago | 15-12G | โ | awaiting T+1 | โ | โ |
Apr 23, 2026 23w ago | 25-NSE | $21.53 $21.53 | ยท 0.00% | โผ โ0.78% | โ |
Apr 23, 2026 23w ago | 8-K | $21.53 $21.53 | ยท 0.00% | โผ โ0.78% | โ |
Apr 17, 2026 23w ago | 10-K/A | $21.48 $21.49 | โฒ +0.05% | โฒ +0.70% | โ |
Mar 6, 2026 30w ago | Press Release | $21.20 $21.33 | โฒ +0.61% | โผ โ0.23% | โ |
Feb 24, 2026 31w ago | 8-K | $10.92 $10.65 | โผ โ2.43% | โผ โ1.88% | โ |
Showing 6 of 6
US Market Status
Market Open โ Closes in 2h 17m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access